This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
BellRing Brands Inc. (BRBR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNY
Is BellRing Brands (BRBR) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
BellRing Brands (BRBR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
BellRing Brands (BRBR) Upgraded to Buy: Here's Why
by Zacks Equity Research
BellRing Brands (BRBR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BellRing Brands (BRBR) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
BellRing Brands (BRBR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
BellRing Brands Inc. (BRBR) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BellRing Brands (BRBR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
BellRing Brands (BRBR) delivered earnings and revenue surprises of 10.26% and 5.51%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Should JPMorgan Diversified Return U.S. Small Cap Equity ETF (JPSE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPSE
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
Is Arcellx (ACLX) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Arcellx, Inc. (ACLX) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Top-Rated Stocks to Buy from a Variety of Sectors After Earnings
by Shaun Pruitt
Outside of popular names in headlines finding stocks that appear to be on a path to prosperity after reporting quarterly results is not always easy but here are several stocks from a variety of sectors that have become more intriguing.
BellRing Brands Inc. (BRBR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BellRing Brands (BRBR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
BellRing Brands (BRBR) delivered earnings and revenue surprises of 6.25% and 1.01%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks Set to Beat on Earnings Today After the Closing Bell
by Nalak Das
We have narrowed our search to five stocks that are set to declare earnings results on Aug 7 after the closing bell. These are: CHGG, ACM, AEL, PLTR, BRBR.
Will BellRing Brands (BRBR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
BellRing Brands (BRBR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Accelerate Diagnostics (AXDX) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Accelerate Diagnostics (AXDX) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Zacks.com featured highlights Stride, BellRing, Linde and AMETEK
by Zacks Equity Research
Stride, BellRing, Linde and AMETEK have been highlighted in this Screen of The Week article.
Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. Stride (LRN), BellRing Brands (BRBR), Linde (LIN) and AMETEK (AME) are sound enough to meet financial obligations.
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Brookdale Senior Living (BKD) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
2 Top-Rated Medical Stocks to Buy After Earnings
by Shaun Pruitt
As we round out this week's earnings lineup, a few healthcare companies are standing out after topping their quarterly earnings expectations.
Best Momentum Stocks to Buy for May 11th
by Zacks Equity Research
PERI and BRBR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 11, 2023.
BellRing Brands (BRBR) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
BellRing Brands (BRBR) delivered earnings and revenue surprises of 14.29% and 4.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Suncor's (SU) Q1 Earnings Preview: Key Things to Consider
by Zacks Equity Research
Suncor Energy (SU) beat the Zacks Consensus Estimate in each of the last four quarters, which resulted in an earnings surprise of 11.6%, on average.
McKesson (MCK) to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
DaVita (DVA) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
High labor costs and inflationary pressures are likely to have weighed on DaVita's (DVA) first-quarter top line.